NCT06620042View on ClinicalTrials.gov

FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

November 15, 2025

Study Completion Date

December 1, 2025

Conditions
Bipolar DepressionTreatment Resistant Bipolar Depression
Interventions
DRUG

Ketamine

Open-label Ketamine

OTHER

Functional magnetic resonance imaging (fMRI)

Functional magnetic resonance imaging (fMRI) of the brain

Trial Locations (2)

44113

Cleveland Clinic Lutheran Hospital, Cleveland

Cleveland Clinic Lutheran Hospital, Ohio City

All Listed Sponsors
lead

Brian Barnett

OTHER

NCT06620042 - FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression | Biotech Hunter | Biotech Hunter